Down-regulation of kallikrein-related peptidase 5 (KLK5) expression in breast cancer patients: A biomarker for the differential diagnosis of breast lesions

被引:23
作者
Avgeris M. [1 ]
Papachristopoulou G. [1 ,2 ]
Polychronis A. [2 ]
Scorilas A. [1 ]
机构
[1] Department of Biochemistry and Molecular Biology, University of Athens, Panepistimiopolis
[2] Oncological Hospital G.Gennimatas IKA-ETAM of Athens, 11473 Athens
关键词
Breast Cancer; Cancer Biomarkers; Kallikreins; KLK5; KLKs; Proteolysis; Serine Proteases; Tumor Markers;
D O I
10.1186/1559-0275-8-5
中图分类号
学科分类号
摘要
Background: Kallikrein-related peptidase 5 (KLK5) is a secreted trypsin-like protease of the KLK family, encoded by the KLK5 gene. KLK5 has been found to cleave various extracellular matrix components, as well as to activate several other KLK proteases, triggering the stimulation of tissue microenvironment proteolytic cascades. Material and Methods. KLK5 expression levels were quantified in 102 cancerous and benign breast tissue specimens, obtained by randomly chosen patients, using RT-qPCR assay. Subsequently, advanced biostatistics were applied in order to analyze the KLK5 expression profile in the two patients' cohorts and also to evaluate its clinical significance for the discrimination of breast tumors. Results: A statistically significant (p < 0.001) down-regulation of the KLK5 expression levels were observed in the malignant specimens compared to the benign ones. Logistic regression and ROC curve analysis revealed the significant (p < 0.001) and the independent (p < 0.001) value of the KLK5 expression quantification, for the discrimination of the malignant from the benign mammary gland biopsies. Moreover, KLK5 expression levels correlate with the pre-menopausal status (p < 0.005) as well as the ER-negative staining (p = 0.028) of women with breast cancer. Conclusions: The quantification of KLK5 expression in breast tissue biopsies may be considered as a novel and independent biomarker for the differential diagnosis between malignant and benign tumors of the mammary gland. © 2011 Avgeris et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 30 条
[1]  
Yousef G.M., Chang A., Scorilas A., Diamandis E.P., Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4, Biochem Biophys Res Commun, 276, pp. 125-133, (2000)
[2]  
Borgono C.A., Diamandis E.P., The emerging roles of human tissue kallikreins in cancer, Nature Reviews Cancer, 4, 11, pp. 876-890, (2004)
[3]  
Sotiropoulou G., Pampalakis G., Diamandis E.P., Functional roles of human kallikrein-related peptidases, J Biol Chem, 284, pp. 32989-32994, (2009)
[4]  
Oikonomopoulou K., Diamandis E.P., Hollenberg M.D., Kallikrein-related peptidases: Proteolysis and signaling in cancer, the new frontier, Biol Chem, 391, pp. 299-310, (2010)
[5]  
Avgeris M., Mavridis K., Scorilas A., Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies, Biol Chem, 391, pp. 505-511, (2010)
[6]  
Mavridis K., Scorilas A., Prognostic value and biological role of the kallikrein-related peptidases in human malignancies, Future Oncol, 6, pp. 269-285, (2010)
[7]  
Jemal A., Siegel R., Xu J., Ward E., Cancer statistics, 2010, CA Cancer J Clin, 60, pp. 277-300, (2010)
[8]  
Yousef G.M., Diamandis E.P., The new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulation, Journal of Biological Chemistry, 274, 53, pp. 37511-37516, (1999)
[9]  
Brattsand M., Egelrud T., Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation, Journal of Biological Chemistry, 274, 42, pp. 30033-30040, (1999)
[10]  
Michael I.P., Sotiropoulou G., Pampalakis G., Magklara A., Ghosh M., Wasney G., Diamandis E.P., Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression, Journal of Biological Chemistry, 280, 15, pp. 14628-14635, (2005)